Einzeltreffer — DigiBib

Background/aim: The aim of the study was to prospectively compare I-131 postablation Whole Body scan (WBS) and Single Photon Emission Computerized Tomography/Computerized Tomography (SPECT/CT) scan on thyroid cancer patients.

Patients and Methods: Overall, 58 patients with papillary thyroid carcinoma were submitted to total thyroidectomy and I-131 remnant ablation. Post-ablation WBS and SPECT/CT scans performed on the same day were compared. Results of SPECT/CT were confirmed by neck and upper mediastinum ultrasound scan and on specific cases by a fully diagnostic CT scan, other tests and definitive histology acting as the gold standard. A total of 36/58 patients were followed-up for 5 years to detect relapse.

Results: Mac Nemar Chi square and Fisher's exact tests disclosed statistically significant differences between WBS and SPECT/CT scan, concerning cervical lymphadenopathy detection (p=0.031) and relapse prediction by NM stage (p=0.033), respectively; SPECT/CT was more accurate in both comparisons.

Conclusion: In papillary thyroid carcinoma I-131 post-ablation SPECT/CT scan detects cervical lymphadenopathy and predicts relapse by NM stage more accurately than WBS.

Titel:	I-131 Postablation SPECT/CT Predicts Relapse of Papillary Thyroid Carcinoma more Accurately than Whole Body Scan.
Autor/in / Beteiligte Person:	Malamitsi, JV ; Koutsikos, JT ; Giourgouli, SI ; Zachaki, SF ; Pipikos, TA ; Vlachou, FJ ; Prassopoulos, VK
Link:	Full Text Finder (Volltext)
Zeitschrift:	In vivo (Athens, Greece), Jg. 33 (2019-11-01), Heft 6, S. 2255-2263
Veröffentlichung:	<2000- > : Attiki, Greece : International Institute of Anticancer Research ; <i>Original Publication</i>: Athens : Dr. J.G. Delinassios, 2019
Medientyp:	academicJournal
ISSN:	1791-7549 (electronic)
DOI:	10.21873/invivo.11731
Schlagwort:	Adult Aged Aged, 80 and over Biomarkers Female Humans Male Middle Aged Recurrence Sensitivity and Specificity Thyroid Cancer, Papillary therapy Iodine Radioisotopes Thyroid Cancer, Papillary diagnosis Tomography, Emission-Computed, Single-Photon methods Tomography, Emission-Computed, Single-Photon standards Tomography, X-Ray Computed methods Tomography, X-Ray Computed standards Whole Body Imaging methods Whole Body Imaging standards
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: English Publication Type: Journal Article Language: English [In Vivo] 2019 Nov-Dec; Vol. 33 (6), pp. 2255-2263. MeSH Terms: Iodine Radioisotopes* ; Tomography, Emission-Computed, Single-Photon* / methods ; Tomography, Emission-Computed, Single-Photon* / standards ; Tomography, X-Ray Computed* / methods ; Tomography, X-Ray Computed* / standards ; Whole Body Imaging* / methods ; Whole Body Imaging* / standards ; Thyroid Cancer, Papillary / *diagnosis ; Adult ; Aged ; Aged, 80 and over ; Biomarkers ; Female ; Humans ; Male ; Middle Aged ; Recurrence ; Sensitivity and Specificity ; Thyroid Cancer, Papillary / therapy References: Clin Nucl Med. 2004 Dec;29(12):795-8. (PMID: 15545881) ; J Clin Endocrinol Metab. 2009 Jun;94(6):2075-84. (PMID: 19276233) ; Mol Imaging Radionucl Ther. 2018 Oct 09;27(3):99-106. (PMID: 30317832) ; Radiographics. 2017 Jan-Feb;37(1):298-315. (PMID: 28076008) ; J Nucl Med. 2003 Dec;44(12):1905-10. (PMID: 14660715) ; Cancer Imaging. 2017 Jan 13;17(1):2. (PMID: 28086986) ; Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1462-6. (PMID: 20358197) ; PLoS One. 2018 Aug 17;13(8):e0202644. (PMID: 30118516) ; Eur J Endocrinol. 2011 Jun;164(6):961-9. (PMID: 21471170) ; J Clin Endocrinol Metab. 2003 Aug;88(8):3668-73. (PMID: 12915653) ; Thyroid. 2012 Aug;22(8):784-90. (PMID: 22780573) ; J Nucl Med. 2009 Feb;50(2):184-90. (PMID: 19164225) ; J Nucl Med Technol. 2014 Sep;42(3):170-80. (PMID: 25190758) ; Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):886-93. (PMID: 19169681) ; Br J Radiol. 2018 Nov;91(1091):20180136. (PMID: 30260232) ; Eur J Nucl Med Mol Imaging. 2004 Oct;31(10):1435-42. (PMID: 15221294) ; Nucl Med Commun. 2012 Aug;33(8):787-98. (PMID: 22669053) ; J Nucl Med. 2009 Jan;50(1):18-23. (PMID: 19091884) ; J Clin Endocrinol Metab. 1994 Mar;78(3):629-34. (PMID: 8126134) ; AJR Am J Roentgenol. 2008 Dec;191(6):1785-94. (PMID: 19020251) ; Anticancer Res. 2003 May-Jun;23(3C):2973-6. (PMID: 12926147) ; Radiology. 2012 Dec;265(3):902-9. (PMID: 23012466) ; Lancet. 2003 Feb 8;361(9356):501-11. (PMID: 12583960) ; Ann Nucl Med. 2011 Nov;25(9):609-15. (PMID: 21725630) ; Thyroid. 2016 Jan;26(1):1-133. (PMID: 26462967) ; Thyroid. 2000 Jul;10(7):573-7. (PMID: 10958309) ; Eur J Nucl Med Mol Imaging. 2013 May;40(5):768-78. (PMID: 23242250) ; Endocrine. 2017 Jun;56(3):551-559. (PMID: 27709475) ; Anticancer Res. 2003 Sep-Oct;23(5b):4235-8. (PMID: 14666632) ; Nucl Med Commun. 2013 Dec;34(12):1216-22. (PMID: 24128897) Contributed Indexing: Keywords: I-131 postablation scan; Papillary thyroid carcinoma; SPECT/CT; whole body scan Substance Nomenclature: 0 (Biomarkers) ; 0 (Iodine Radioisotopes) ; 0 (Iodine-131) Entry Date(s): Date Created: 20191031 Date Completed: 20200313 Latest Revision: 20200313 Update Code: 20231215 PubMed Central ID: PMC6899111

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

I-131 Postablation SPECT/CT Predicts Relapse of Papillary Thyroid Carcinoma more Accurately than Whole Body Scan.